Comparison Between ex Vivo and in Vivo Injection of Blue Dye in Sentinel Lymph Node Mapping for Colon Cancer

Chung-Ang University

Status: Unknown

Conditions: Colon Cancer; Sentinel Lymph Node Biopsy

Treatments: Procedure: Intraoperative injection (in vivo); Procedure: Postoperative injection (ex vivo)

Study type: Interventional

Funder types: Other

Identifiers

NCT00654342

caugs_01

Details and patient eligibility

About

The technique of sentinel lymph node mapping in patients with colon cancer varies among reports, and the optimal method remain to be established. The purpose of this study was to determine the optimal injection technique for sentinel lymph node mapping for colon cancer.

Enrollment: 100 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Stage I - III colon cancer patients

Exclusion criteria

• cancer located at the low rectum which were located within 10 cm of the dentate, recurrent or metastatic colon carcinoma, adjacent organ invasion tumor, prior chemotherapy or radiation, cancer with intestinal obstruction, past intestinal surgery

Trial design

100 participants in 2 patient groups

1

Other group

Description:

In vivo injection group

Treatment:

Procedure: Intraoperative injection (in vivo)

2

Other group

Description:

Ex vivo injection group

Treatment:

Procedure: Postoperative injection (ex vivo)